| Literature DB >> 33329466 |
Evelyn Sun1, Marcia L Graves1, David C Oliver1.
Abstract
The University of British Columbia has developed a course-based undergraduate research experience (CURE) that engages students in authentic molecular microbiology research. This capstone course is uniquely built around an open-access online undergraduate research journal entitled Undergraduate Journal of Experimental Microbiology and Immunology (UJEMI). Students work in teams to derive an original research question, formulate a testable hypothesis, draft a research proposal, carry out experiments in the laboratory, and publish their results in UJEMI. The CURE operates in a feed forward manner whereby student-authored UJEMI publications drive research questions in subsequent terms of the course. Progress toward submission of an original manuscript is scaffolded using a series of communication assignments which facilitate formative development. We present a periodic model of our CURE that guides students through a research cycle. We review two ongoing course-based projects to highlight how UJEMI publications prime new research questions in the course. A journal-driven CURE represents a broadly applicable pedagogical tool that immerses students in the process of doing science.Entities:
Keywords: STEM-science technology engineering mathematics; course-based undergraduate research experience; curriculum; molecular microbiology; pedagogy; scientific enculturation; undergraduate research journal
Year: 2020 PMID: 33329466 PMCID: PMC7719674 DOI: 10.3389/fmicb.2020.589025
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
FIGURE 1Research cycle over a 16 week academic term. Planning, experimentation, and dissemination phases are denoted. Due dates for communication assignments and feedback scaffolding the CURE are shown on the periphery. Individual proposals are submitted after the first week of classes. The team proposal is submitted at the conclusion of the planning phase in week 6. Teams conduct oral presentations on week 12 at the beginning of the dissemination phase. Draft manuscripts are submitted at the end of week 14 and the final manuscript just before the end of the course around week 15.
FIGURE 2UJEMI case studies demonstrate how each CURE build on each other over time. (A) Left: working model of proteins involved in the secretion of capsule in E. coli strain K30 (reprinted with permission, Yuen et al., 2017). Gene products discussed include Wza (red), Wzb (green), Wzc (blue). Capsule subunits are shown in small blue and black circles. Auxiliary secretion machinery subunits (Wzx, Wzy) are not discussed in the text. Right: Plasmid map, PI2-MBP fusion protein domain architecture, and primary amino acid sequence of PI2 (reprinted with permission, Grewal et al., 2020). Cysteine residues are shown in bold font. (B) Chronology of ongoing CURE-based research projects published in UJEMI investigating the capsule on antibiotic resistance (left, blue/red project nodes) and the expression and purification of protease inhibitor 2 (PI2) (right, purple/red project nodes). Projects are labeled with the name of the first author in the corresponding UJEMI publication (refer to Supplementary Table S1). Projects sharing similar research aims are depicted as the same shape project node. The red project nodes represent research articles describing key advancements in each project.